Form 4 for ABBV AbbVie
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001415889-24-029754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-18 | 2024-12-16 | ABBV | Buckbee Kevin K | SVP, Ctrl | M - OptEx | $93.50 | +1,800 | 8,783 | +26% | +$168.3K |
| D | 2024-12-18 | 2024-12-16 | ABBV | Buckbee Kevin K | SVP, Ctrl | S - Sale+OE | $172.24 | -1,800 | 6,983 | -20% | -$310.0K |
| D | 2024-12-18 | 2024-12-16 | ABBV | Buckbee Kevin K | SVP, Ctrl | M - OptEx | $93.50 | -1,800 | 12.1K | -13% | -$168.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2024-12-16 | M | A | 1,800 | $93.50 | 8,783 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2024-12-16 | S | D | 1,800 | $172.24 | 6,983 | D | — | — | |
| 3 | Derivative | Option (Right to buy) | 2024-12-16 | M | D | 1,800 | $93.50 | 12,111 | D | $93.50 · 2021-02-20 to 2030-02-19 | 1,800 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |